对巨核细胞产生前血小板的无标记高内涵分析
研究设计了一个开源、高通量、无标记的分析平台,对活体原代巨核细胞进行24小时相差显微镜成像,利用基于像素的机器学习分类和定制CellProfiler流程量化前血小板生成。该平台可输出前血小板生成百分比、面积、计数及骨架化信息,并用已知引起血小板减少的化合物验证了其发现药物新效应的能力。
要点
- 平台整合ilastik概率图与CellProfiler Analyst强化分类,自动识别圆形巨核细胞和分支前血小板。
- 输出指标包括前血小板生成百分比、面积、计数及骨架化分支长度,建议联合面积测量评估体外前血小板生成。
- 用溴结构域抑制剂等已知致血小板减少化合物测试,发现药物对前血小板形成此前未认识的影响。
核心结论
- 该无偏数据分析平台可扩大前血小板生成研究的规模和范围,并可能成为研究血小板减少分子机制的有价值资源。
研究设计与样本
- 方法学研究:设计开源、高内涵、高通量、无标记分析平台,对活体原代巨核细胞进行24小时相差成像。
- 采用ilastik基于像素的机器学习分类生成关键细胞特征概率图,经定制CellProfiler流程按形态识别过滤目标结构。
- 再由CellProfiler Analyst进行强化分类以改善细胞结构检测。
主要发现
- 流程可输出前血小板生成百分比、面积、前血小板与巨核细胞计数及骨架化分支长度等信息。
- 作者提出联合分析指标、尤其巨核细胞和前血小板的面积测量来评估体外前血小板生成。
- 准确性经手动计数图像和现有算法验证。
- 用溴结构域抑制剂等已知致血小板减少化合物测试,发现药物对前血小板形成此前未认识的影响。
临床怎么用
- 作者提出在评估体外前血小板生成时可联合使用该平台分析指标,尤其巨核细胞和前血小板的面积测量。
- 作者认为该平台可能作为研究血小板减少分子机制的有价值资源。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanisms that regulate platelet biogenesis remain unclear; factors that trigger megakaryocytes (MKs) to initiate platelet production are poorly understood. Platelet formation begins with proplatelets, which are cellular extensions originating from the MK cell body. OBJECTIVES: Proplatelet formation is an asynchronous and dynamic process that poses unique challenges for researchers to accurately capture and analyze. We have designed an open-source, high-content, high-throughput, label-free analysis platform. METHODS: Phase-contrast images of live, primary MKs are captured over a 24-hour period. Pixel-based machine-learning classification done by ilastik generates probability maps of key cellular features (circular MKs and branching proplatelets), which are processed by a customized CellProfiler pipeline to identify and filter structures of interest based on morphology. A subsequent reinforcement classification, by CellProfiler Analyst, improves the detection of cellular structures. RESULTS: This workflow yields the percent of proplatelet production, area, count of proplatelets and MKs, and other statistics including skeletonization information for measuring proplatelet branching and length. We propose using a combination of these analyzed metrics, in particular the area measurements of MKs and proplatelets, when assessing in vitro proplatelet production. Accuracy was validated against manually counted images and an existing algorithm. We then used the new platform to test compounds known to cause thrombocytopenia, including bromodomain inhibitors, and uncovered previously unrecognized effects of drugs on proplatelet formation, thus demonstrating the utility of our analysis platform. CONCLUSION: This advance in creating unbiased data analysis will increase the scale and scope of proplatelet production studies and potentially serve as a valuable resource for investigating molecular mechanisms of thrombocytopenia.
引用
- French SL, Vijey P, Karhohs KW, et al. High-content, label-free analysis of proplatelet production from megakaryocytes. J Thromb Haemost. 2020. PMID: 32662223. doi:10.1111/jth.15012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。